National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
In 111 ibritumomab tiuxetan (... ih-brih-TOO-moh-mab ty-oo-EKS-eh-tan)

 A radiolabeled monoclonal antibody that is used to detect certain types of B-cell non-Hodgkin lymphoma and is being studied in the detection of other types of B-cell tumors. It is made up of the monoclonal antibody ibritumomab plus the radioisotope indium 111. It binds to the protein called CD20, which is found on B cells. A machine is used to detect which cells in the body have bound the antibody. In 111 ibritumomab tiuxetan is a type of radiopharmaceutical. Also called indium In 111 ibritumomab tiuxetan and In 111 Zevalin.

Previous Definitions:implantable cardioverter-defibrillator, implantable pump, impotence, impotent, IMRT
Next Definitions:In 111 Zevalin, in vitro, in vitro fertilization, in vivo, inalimarev